https://cenobamate.in/
Cenobamate (Xcopri/Ontozry) — Patient Information Guide | Gujarat Epilepsy
Complete patient guide for Cenobamate (Xcopri/Ontozry) — dosing, side effects, DRESS risk, drug interactions, and when to call your doctor. By Gujarat Epilepsy...
patient information guidegujaratepilepsy
https://www.xcopri.com/
Epilepsy Medication | XCOPRI (cenobamate tablets) CV
Jan 9, 2026 - Explore XCOPRI, a prescription medication for seizures indicated for the treatment of partial-onset seizures in adults patients
epilepsymedicationtabletscv
https://freidok.uni-freiburg.de/data/244460
FreiDok plus - Onset of efficacy and adverse events during Cenobamate titration period
https://pubmed.ncbi.nlm.nih.gov/34145528/
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate...
Epilepsy is one of the most common and disabling chronic neurological disorders. Antiseizure medications (ASMs), previously referred to as anticonvulsant or...
https://adisinsight.springer.com/drugsafety/803927011?error=cookies_not_supported&code=84c5b4c2-5447-456f-ba66-5d00c55e72d2
Cenobamate/Levetiracetam/Clobazam - AdisInsight
A report described a patient who experienced drug overdose with cenobamate, levetiracetam and clobazam.
levetiracetamclobazamadisinsight
https://www.prnewswire.com/news-releases/sk-biopharmaceuticals-wins-export-award-for-cenobamate-301694350.html
SK Biopharmaceuticals Wins Export Award for Cenobamate
/PRNewswire/ -- SK Biopharmaceuticals, an innovative global pharmaceutical company, announced that it has received recognition from the Korean government as...
skbiopharmaceuticalswinsexportaward
https://adisinsight.springer.com/trials/700360849?error=cookies_not_supported&code=fb4640f8-3405-4227-933e-d79e70c54025
A prospective study assessing safety and efficacy of cenobamate (CNB) as adjunctive therapy in...
To assess the safety and efficacy of cenobamate (CNB) as adjunctive therapy in adult patients with focal onset seizures participating in an early access
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1239152/full
Frontiers | Cenobamate as add-on therapy for drug resistant epilepsies: effectiveness, drug to drug...
Background: Cenobamate (CNB) is an anti-seizure medication (ASM) approved in 2021 in Europe for adjunctive treatment of focal-onset seizures in adults who we...
add on